glp 1 and anesthesia risk glp-1 news Are Serious Risks of Semaglutide Other Agonists Under-Recognized? Case Reports of Retained Solid Gastric Contents in Patients Undergoing Anesthesia anesthesia glp-1 guidance news Guidelines – How should we approach patients

Thats why GLP-1s show up in clinical trials for cardiovascular disease, kidney disease, heart failure, dementia, NASH (fatty liver), and cancer

GLP-1 medications alter the environment in which gut bacteria operate, and early research suggests this can shift microbial populations in ways that may contribute to digestive symptoms

That could have the effect of increasing Part D premiums across the board, although Medicare Advantage plans can use rebates to buy down Part D premiums, but this is not an option for stand-alone PDPs

The new weight loss medications commonly result in weight loss ranging anywhere from 10% to 20% from baseline, with 25% weight loss observed in some of the latest clinical trials